Aminocaproic Acid

plasminogen activator, tissue type ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33212896 Enhanced Antifibrinolytic Efficacy of a Plasmin-Specific Kunitz-Inhibitor (60-Residue Y11T/L17R with C-Terminal IEK) of Human Tissue Factor Pathway Inhibitor Type-2 Domain1. 2020 Nov 17 1
2 30722079 Fibrin Modulates Shear-Induced NETosis in Sterile Occlusive Thrombi Formed under Haemodynamic Flow. 2019 Apr 1
3 28007568 Hyaluronic acid decreases the mechanical stability, but increases the lytic resistance of fibrin matrices. 2017 Nov 1
4 12738809 Pericellular plasmin induces smooth muscle cell anoikis. 2003 Jul 2
5 14743974 Mechanism of the stimulatory effect of 6-aminohexanoic acid on plasminogen activation by streptokinase or tissue plasminogen activator: the role of chloride. 2003 Oct-Dec 2
6 12658774 Study on the mechanism of the annexin II-mediated co-assembly of t-PA and plasminogen. 2002 1
7 11112095 Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator. 2000 Apr-Jun 2
8 9836589 The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. 1998 Dec 1 1
9 7721771 Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules. 1995 Apr 14 1
10 7759476 The role of the lysyl binding site of tissue-type plasminogen activator in the interaction with a forming fibrin clot. 1995 May 26 2
11 8533120 Effect of fucoidan during activation of human plasminogen. 1995 Aug 1 4
12 8869642 Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. 1995 Dec 1
13 7804168 Binding of tissue-type plasminogen activator (t-PA) to Neisseria meningitidis and Haemophilus influenzae. 1994 Aug 1
14 8063741 An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. 1994 Aug 19 1
15 8073394 Inhibitory effects of lysine analogues on t-PA induced whole blood clot lysis. 1994 Mar 15 2
16 8112348 Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen. 1994 Feb 1 2
17 1309292 Direct identification of lysine-33 as the principal cationic center of the omega-amino acid binding site of the recombinant kringle 2 domain of tissue-type plasminogen activator. 1992 Jan 1
18 1326962 Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells. 1992 Sep 16 1
19 1525179 One-step purification of tissue-type plasminogen activator using affinity chromatography with a special monoclonal antibody under mild conditions. 1992 Sep 15 5
20 1909331 Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. 1991 Sep 5 1
21 2145980 Effects of intact fibrin and partially plasmin-degraded fibrin on kinetic properties of one-chain tissue-type plasminogen activator. 1990 Oct 18 1
22 2510823 Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments. 1989 Sep 5 1
23 2555642 Tissue plasminogen activator and plasmin independently decrease human neutrophil activation. 1989 2
24 3146348 Effectors of the activation of human [Glu1]plasminogen by human tissue plasminogen activator. 1988 Aug 23 2